Workflow
Deadline Alert: Open Lending Corporation (LPRO) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit
GlobeNewswire News Room· 2025-06-05 17:19
LOS ANGELES, June 05, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP reminds investors of the upcoming June 30, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Open Lending Corporation (“Open Lending” or the “Company”) (NASDAQ: LPRO) securities between February 24, 2022 and March 31, 2025, inclusive (the “Class Period”). IF YOU SUFFERED A LOSS ON YOUR OPEN LENDING INVESTMENTS, CLICK HERE TO INQUIRE ABOUT POTENTIALLY PUR ...
Deadline Alert: Iovance Biotherapeutics, Inc. (IOVA) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit
GlobeNewswire News Room· 2025-06-05 17:19
LOS ANGELES, June 05, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP reminds investors of the upcoming July 14, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Iovance Biotherapeutics, Inc. (“Iovance” or the “Company”) (NASDAQ: IOVA) securities between May 9, 2024 and May 8, 2025, inclusive (the “Class Period”). IF YOU SUFFERED A LOSS ON YOUR IOVANCE INVESTMENTS, CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS T ...
Shareholders that lost money on UroGen Pharma Ltd. (URGN) Urged to Join Class Action – Contact Levi & Korsinsky to Learn More
GlobeNewswire News Room· 2025-06-05 17:17
NEW YORK, June 05, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in UroGen Pharma Ltd. ("UroGen Pharma Ltd." or the "Company") (NASDAQ: URGN) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of UroGen Pharma Ltd. investors who were adversely affected by alleged securities fraud between July 27, 2023 and May 15, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/urogen-p ...
Alaska Air's Arm to Launch New Flights for Boosting Connectivity
ZACKS· 2025-06-05 17:15
Key Takeaways Alaska Airlines will launch nonstop Seattle-Rome service in May 2026 using a Boeing 787-9 Dreamliner. ALK is building Seattle into a global gateway with Rome as its third widebody international destination. The new route supports ALK's "Alaska Accelerate" strategy to boost profit and West Coast connectivity.In a bid to broaden its network, Alaska Airlines, a wholly owned subsidiary of Alaska Air Group (ALK) ), will start a new nonstop service between Seattle and Rome. The service will commen ...
VNOM $4.1B Deal Echoes Permian Appeal: Time to Watch EPD & OXY too?
ZACKS· 2025-06-05 17:15
Key Takeaways VNOM is acquiring Sitio Royalties for $4.1B to expand its Permian footprint to 85,700 net royalty acres. The deal affirms Permian profitability, with VNOM projecting an output of up to 130,000 BOE per day by 4Q25. With activity in the Permian gaining momentum, this can signal a promising business outlook for EPD and OXY.Viper Energy, Inc.’s (VNOM) decision to buy Sitio Royalties is making headlines — not just because it is a major deal but because of what it reveals about the oil market. The ...
Contact Levi & Korsinsky by July 14, 2025 Deadline to Join Class Action Against Iovance Biotherapeutics, Inc. (IOVA)
GlobeNewswire News Room· 2025-06-05 17:14
NEW YORK, June 05, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Iovance Biotherapeutics, Inc. ("Iovance" or the "Company") (NASDAQ: IOVA) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Iovance investors who were adversely affected by alleged securities fraud between May 9, 2024 and May 8, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/iovance-biotherapeutic ...
Tesla shares tumble as Trump, Musk escalate attacks: ‘Elon's politics continue to harm stock'
New York Post· 2025-06-05 17:11
Elon Musk, CEO of Tesla and self-proclaimed “First Buddy” of President Trump, has stepped up criticism of the president’s massive tax legislation in recent days. Investors are starting to notice.Tesla shares dropped more than 5% on Thursday on a day otherwise devoid of news for the electric vehicle maker, leading traders to speculate that Musk’s increasingly pointed rhetoric suggests strain in the relationship that has benefited his sprawling empire of businesses.President Trump said on Thursday that Musk w ...
Here's Why You Should Add PacBio Stock to Your Portfolio Now
ZACKS· 2025-06-05 17:11
Key Takeaways PacBio beat first-quarter estimates with higher margins and a narrower adjusted operating loss. PACB's Revio and Vega systems drove adoption across research, clinical, and academic markets. PacBio targets $45 to $50 million in annual cost savings via restructuring by the end of 2025.Pacific Biosciences of California, Inc. (PACB) , popularly known as PacBio, has been gaining from its continued product development. The optimism, led by decent first-quarter results, is expected to contribute fu ...
5 Bargain Stocks With Low P/S Ratios & High Growth Return Potential
ZACKS· 2025-06-05 17:11
Key Takeaways The P/S ratio helps uncover value in early growth or unprofitable firms wherein earnings are minimal. Value picks were screened using P/S, P/E, P/B, debt/equity, price floor, the Zacks Rank and the Value Score. JAKK, GDOT, SIG, ROCK and PFE show low price-to-sales ratios with solid upside potential.Investing in stocks based on valuation metrics is considered a smart strategy. The price-to-earnings (P/E) ratio is often the go-to metric due to its simplicity and ease of use. However, the price ...
Rigetti Rides Quantum Momentum: Will Strategic Deals Boost Growth?
ZACKS· 2025-06-05 17:11
Key Takeaways RGTI formed a partnership with Quanta, including a $35 million equity investment to boost development. Rigetti and Quanta will each invest over $100 million in five years to scale quantum processors. RGTI aims to deploy Ankaa-3 and leverage Quanta's scale to enter the enterprise and academic sector.Rigetti Computing (RGTI) marked a significant milestone in February by entering a strategic collaboration with Quanta Computer, a global leader in electronics manufacturing. This agreement reflect ...